North America Breast Cancer Screening Test Market – Size, Outlook, Trends, and Forecast (2024

North America Breast Cancer Screening Test Market - Size

Study Period

2018 - 2030

Base Year For Estimation

2023

Forecast Data Period

2024-2030

Historical Data Period

2018-2021

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Breast cancer screening is to detect cancer in its initial stages. Breast cancer is the one which is out of control growth of cells in the breast. This forms tumours and lumps which can be readily detectable through x-ray. Breast cancer is the one which is the primary cause of mortality among women. Regarding breast cancer screening countries like United States, China, Japan, Germany and United Kingdom constitutes the 60% of the maximum share of breast cancer screening test market.

North America Breast Cancer Screening Test Market Segments size & growth:

The market is valued at USD XX billion in 2017 and is estimated to be USD XX billion by 2024 at a CAGR of XX%. The factors responsible for market growth are mainly due to rise in the incidence of breast cancer, government initiatives for cancer screening programs, awareness among people regarding the screening tests and advancements in breast imaging technologies and adopting highly effective screening test

North America Breast Cancer Screening Test Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

processes.

North America Breast Cancer Screening Test Market Segments share:

The breast cancer screening test market is segmented between tests and end user. By criteria, it is categorised into blood marker tests, imaging tests, genetic tests, and immunohistochemistry. By the end user, it is classified into hospitals, diagnostic centers, cancer industries and research laboratories. In these imaging tests is most commonly used in testing. In imaging test process mammography is the most common screening test and is having the significant market share. Geographically, 60% of the global market share is by North America and 70% of women in the US undergo mammography. North America is holding the most significant market share followed by Europe due to advanced and technological developments and early screening procedures.

North America Breast Cancer Screening Test Market Trends:

Agendia, the MD Anderson cancer centre and Netherlands cancer institute partners to integrate technologies and data to improve diagnostics and treatment options for colorectal cancer.
Armune bioscience involved in research and development of a diagnostic and prognostic test for prostate, lung and breast cancer which allow physicians to make more personalised and advanced treatment decisions for better prognosis.

North America Breast Cancer Screening Test Market Research Reports Include:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary market players are:

A&G Pharmaceutical, Inc.
Armune Bioscience, Inc.
Genomic Health, Inc.
Agendia BV
BioMark Technologies Inc.

cancer. Armune bioscience involved

You can also purchase parts of this report. Do you want to check out a section wise price list

North America Breast Cancer Screening Test Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.